Navigation Links
Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
Date:4/17/2008

$558 $525 6% (2%)

--------------------------------------------------------------------------

--------------------------------------------------------------------------

Baxter excluding Transfusion

Therapies $2,833 $2,587 10% 4%

--------------------------------------------------------------------------

--------------------------------------------------------------------------

Transfusion Therapies (4) $44 $88 (50%) (51%)

--------------------------------------------------------------------------

--------------------------------------------------------------------------

TOTAL BAXTER $2,877 $2,675 8% 2%

==========================================================================

(1) Previously referred to as BioSurgery.

(2) Principally includes vaccines, sales of plasma to third parties, and

recombinant FIX (BeneFIX). Sales of BeneFIX ceased as of June 30,

2007.

(3) Prior year BioScience sales data has been reclassified as described in

Note 4.

(4) The TT business was sold on February 28, 2007. The results of

operations of the TT business were previously reported in the

BioScience business. The TT totals above include sales of TT products

through the date of divestiture, as well as revenues associated with

manufacturing, distribution and other services provided by the company

to the buyer of the TT business post-divestiture.

BAXTER INTERNATIONAL INC.

Key Product Line Sales by US and International

Periods Ending March 31, 2008 and 2007

(unaudited)

($ in millions)

-------------------------------------
'/>"/>

SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
2. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
3. Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year
4. Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products
5. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
6. Baxter Kidney Patient Education Program Celebrates Tenth Anniversary
7. Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular Technology
8. Baxter Announces FDA Approval of GELFOAM(R) Plus Hemostasis Kit
9. Baxter International Fourth Quarter 2007 Financial Results Conference Call
10. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
11. Baxters Costa Rica Facility Recognized With Shingo Prize for Excellence in Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... (PRWEB) July 24, 2014 The ... of molecular diagnostic test results. It also enables ... for the validation and reporting of high profile ... diagnostics is a rapidly growing area of biotechnology ... genetic predisposition, cancer, and companion diagnostics in personalized ...
(Date:7/23/2014)... 23, 2014  Sangamo BioSciences, Inc. (NASDAQ: ... results and accomplishments. For the second ... net loss of $7.0 million, or $0.10 per share, ... $0.10 per share, for the same period in 2013. ... cash equivalents, marketable securities and interest receivable of $236.7 ...
(Date:7/23/2014)... the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), the Vienna University of ... succeeded in embedding nearly perfect semiconductor crystals into ... producing hybrid nanowires, very fast and multi-functional processing ... in the future. The research results will be ... , Nano-optoelectronics are considered the cornerstone of future ...
(Date:7/23/2014)... 23, 2014 Shimadzu Scientific Instruments ... acid analysis system developed jointly with Ajinomoto Co. ... can analyze 38 amino acids in nine minutes, ... achieves high-speed analysis utilizing a fast application-specific column ... accurate analytical results even under conditions with difficult ...
Breaking Biology Technology:New DNA-barcode Patent Virtually Eliminates False Test Results and Sample Mix-up 2Sangamo BioSciences Reports Second Quarter 2014 Financial Results 2Sangamo BioSciences Reports Second Quarter 2014 Financial Results 3Sangamo BioSciences Reports Second Quarter 2014 Financial Results 4Sangamo BioSciences Reports Second Quarter 2014 Financial Results 5Sangamo BioSciences Reports Second Quarter 2014 Financial Results 6Sangamo BioSciences Reports Second Quarter 2014 Financial Results 7Sangamo BioSciences Reports Second Quarter 2014 Financial Results 8Sangamo BioSciences Reports Second Quarter 2014 Financial Results 9A crystal wedding in the nanocosmos 2Shimadzu's New UF-Amino Station Provides High-Speed, Multi-Component Analysis of Amino Acids in Food & Beverage and Pharmaceutical Testing 2
... SAN DIEGO, CA, July 30, 2009 Senomyx, Inc. (Nasdaq: ... on Tuesday, August 4, 2009 before the opening of the U.S. financial ... Internet broadcast that will provide a corporate update and a review of ... Time (8:00 a.m. Pacific Time). , , To participate ...
... , , ALPHARETTA, Ga., July ... announced the appointment of Philip Vogt as Executive Vice President, ... more than thirty years of pharmaceutical experience and will ... to this role, Vogt served as President of Ethex Corporation ...
... SOUTH SAN FRANCISCO, Calif., July 30 Sunesis Pharmaceuticals, ... on the development and commercialization of new oncology therapeutics for ... NASDAQ has approved its application to transfer the listing of ... NASDAQ Capital Market. The transfer will be effective at the ...
Cached Biology Technology:SENOMYX, INC. SECOND QUARTER 2009 EARNINGS CONFERENCE CALL SCHEDULED FOR AUGUST 4, 2009 2Sunesis Receives Approval for Listing on The NASDAQ Capital Market 2Sunesis Receives Approval for Listing on The NASDAQ Capital Market 3
(Date:7/24/2014)... cars ply silent freeways, solar panels blanket rooftops and ... from howling winds and from the blazing desert sun. ... technically and economically feasible to convert California,s all-purpose energy ... in Energy , the plan shows the way ... California that could create tens of thousands of jobs ...
(Date:7/24/2014)... Einstein College of Medicine of Yeshiva University have ... for Parkinson,s Research to translate a basic science finding ... project will test chemical compounds on a newly identified ... acts on an underlying cause of the disease. ... manage their symptoms, we are eager to stop or ...
(Date:7/24/2014)... in the United States, wildland managers often utilize the ... trees (ladder fuels). These cuttings and other post-logging ... danger in order to dispose of the material. To ... often cover all or part of the debris pile ... plastic, in order to keep water out. A recent ...
Breaking Biology News(10 mins):Stanford study shows how to power California with wind, water and sun 2Stanford study shows how to power California with wind, water and sun 3Stanford study shows how to power California with wind, water and sun 4Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinson's 2Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinson's 3Study gives new perspective on agricultural plastic, debris burning, and air quality 2
... tomorrow (14 October) as CSIRO launches in the United ... 2006 in Atlanta, Georgia, the world's largest conference for ... mathematical method, patented by Australia's CSIRO, for automatically tracing ... With up to 40,000 delegates expected, the conference will ...
... for treating a recurrent cancer of the central nervous ... glioma, has shown promising results in preliminary data from ... from the first group of six patients in the ... Center, showed that vitespen (trademarked as Oncophage), a vaccine ...
... a few dozen trillions, a human adult has about 70 ... 959 cells. , Yet we have an awful lot ... been exploring two “highly conserved? cell-signaling pathways for innate immunity ... a lot of common enemies, particularly soil-borne pathogens. C. elegans, ...
Cached Biology News:Vaccine for brain tumors shows promising results 2Vaccine for brain tumors shows promising results 3Worms produce surprise insight into human fever 2
ID clarifier: platform...
The PROTEAN II xi multi-cell 2-D conversion kit converts the PROTEAN II xi multi-cell to the PROTEAN II XL multi-cell for a wider format cell that accepts 17 to 18 cm IPG strips....
The SVT3-2 diverter valve is a 3-port, 2-position valve for use with the BioLogic DuoFlow system....
... is used for vertical electrophoresis applications. The cell accommodates ... L of running buffer. It includes the PROTEAN II ... kit, which contains accessories for use with 2.0 mm ... 2 sets of 20 x 20 cm glass plates, ...
Biology Products: